Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
GRCE
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
GRCE
$1.71
−1.16%
Lists
Call GRCE
Grace Therapeutics
GRCE
Back
Lists
Call GRCE
$1.71
−$0.02 · −1.16%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
22%
in three months and
2%
of the way up its 52-week range.
Call GRCE
Loading chart data...
Signal state
GRCE: Grace Therapeutics, Inc. Stock Analysis | finqOS